Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
FibroGen (FGEN)
NASDAQ:FGEN
Holding FGEN?
Track your performance easily
FibroGen (FGEN) Ownership Overview
2.97% Insiders
19.01% Mutual Funds
11.63% Other Institutional Investors
5.22% ETFs
61.17% Public Companies and
Individual Investors
The ownership structure of FibroGen (FGEN) stock is a mix of institutional, retail, and individual investors. Approximately 35.86% of the company’s stock is owned by Institutional Investors, 2.97% is owned by Insiders, and 61.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 13, 2024 | Deyaa Adib Chief Medical Officer | xxxxxxxxxxxxx | $25884 |
| Mar 11, 2024 | Thane Wettig Ceo,director | xxxxxxxxxxxxx | $95000 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $80255 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $12181105 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,655,948 | Institution | 13.60% | 4,410,871 | |
| 6,282,118 | Institution | 6.26% | 2,029,124 | |
| 5,854,671 | Institution | 5.83% | 1,891,059 | |
| 4,619,552 | Institution | 4.60% | 1,492,115 | |
| 4,297,748 | Institution | 4.28% | 1,388,173 | |
| 1,706,813 | Insider | 1.70% | 551,301 | |
| 889,329 | Institution | 0.89% | 287,253 | |
| 423,316 | Insider | 0.42% | 136,731 | |
| 421,400 | Institution | 0.42% | 136,112 | |
| 322,731 | Institution | 0.32% | 104,242 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,282,118 | Institution | 6.26% | 2,029,124 | |
| 5,854,671 | Institution | 5.83% | 1,891,059 | |
| 4,297,748 | Institution | 4.28% | 1,388,173 | |
| 889,329 | Institution | 0.89% | 287,253 | |
| 421,400 | Institution | 0.42% | 136,112 | |
| 322,731 | Institution | 0.32% | 104,242 | |
| 169,479 | Institution | 0.17% | 54,742 | |
| 161,500 | Institution | 0.16% | 52,165 | |
| 83,978 | Institution | 0.08% | 27,125 | |
| 83,092 | Institution | 0.08% | 26,839 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,916,871 | Institution | 2.91% | 1,164,998 | |
| 1,380,877 | Institution | 1.38% | 551,522 | |
| 321,804 | Institution | 0.32% | 128,529 | |
| 274,279 | Institution | 0.27% | 85,794 | |
| 225,452 | Institution | 0.22% | 72,821 | |
| 120,917 | Institution | 0.12% | 39,056 |
FAQ
Who Owns FibroGen (FGEN)?
According to the latest TipRanks data, approximately 11.63% of the company's stock is held by institutional investors, 2.97% is held by insiders, and 61.17% is held by retail investors.
What percentage of FibroGen (FGEN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 11.63% of FibroGen (FGEN) stock is held by institutional investors.
What percentage of FibroGen (FGEN) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.17% of FibroGen (FGEN) stock is held by retail investors.
Who owns the most shares of FibroGen (FGEN)?
Theofanis Kolokotrones owns the most shares of FibroGen (FGEN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.